Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2000

View Archived Issues

Synsorb Pk receives fast track designation from FDA for prevention of HUS

Enrollment in Altropane PD diagnosis trial now complete

InSite Vision's batimastat eyedrops show antiangiogenic activity

Decitabine effective in myelodysplastic syndrome

Visudyne T-IND program expanded

Medicure's MC-1 shows good results in ischemia models

More good news about Enbrel: NEJM article describes efficacy in juvenile RA

NeoPharm receives milestone payment from P&U for LEP

FDA grants priority review for new once-daily Videx capsules

Calcilytic compounds described by SB for use in disorders of bone or mineral homeostasis

ODAC does not recommend approval of oxaliplatin combination therapy

Novartis discloses new antiangiogenic agents acting on growth factor-mediated signal transmission

Medivir reinitiates development of alovudine for AIDS

New 9-aminocamptothecins endowed with potent antitumor activity

Subtype-selective PDE4 inhibitors claimed by Pfizer for respiratory and other disorders

Phase II results positive for Medivir's shingles antiviral

AstraZeneca pipeline includes novel chemokine receptor modulators

Abbott's new alpha1A-adrenoceptor agonists, their preparation, activity and use

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

German launch for Mifegyne announced

FDA advisory committee recommends approval of Camptosar as first-line therapy of colorectal cancer

New PDT candidate designed by Chinese university researchers

Memory-enhancing effects of huperzine tablets and capsules proven equivalent

Cariporide: no improvement in myocardial stunning/infarct size in GUARDIAN trial subgroup

TxA2 antagonist from Bayer may have potential in atherosclerosis according to ACC presentation

First human data reported for GI-262570 at recent scientific forum

Licensing opportunity from Vita-Invest: fixed-dose antihypertensive combination

Potential for drug interactions of Sch-58235 evaluated in humans

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...